Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Novel Bayer compound stimulates soluble guanylate cyclase

Dec. 5, 2000

Encouraging results reported from early clinical trial of VasoCare for PVD

Dec. 5, 2000

Novel Gardos channel inhibitor improves RBC dehydration and sickling in transgenic mouse model

Dec. 4, 2000

Kyowa Hakko reveals newest inhibitors of PDE5 and their potential therapeutic applications

Dec. 4, 2000

Inhibitors of NHE and their use in cardiovascular disorders claimed by BMS

Dec. 4, 2000

Biological activity of new member of VEGF family confirmed by Collateral Therapeutics

Dec. 4, 2000

Prous Science Puts Postgraduate Training Online

Dec. 1, 2000

Protherics' angiotensin vaccine heads for phase II

Dec. 1, 2000

FDA grants orphan drug status for Eurogene's Trinam

Nov. 30, 2000

Piperidine-based renin inhibitors and their use described by Roche

Nov. 29, 2000

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.